TGFB1 and pulmonary arterial hypertension: Importantly, loss of BMPR2 has been linked to increased inflammation and proliferation of pulmonary ECs, and contributes to abnormal vascular remodelling in PAH [42], and either enhanced BMP signalling or inhibition of TGF-β signalling reduced the development of PAH in pre-clinical models [43–46].